Antiplatelet Therapy Just Got Personal.
Not Everyone Responds Equally
Today, millions of patients suffer from one or more types of cardiovascular disease1. Physicians may have prescribed these patients a regular antiplatelet medication such as aspirin, Plavix® or Effient® to prevent heart attacks, stroke and other potentially
life-threatening cardiovascular events.
Studies have shown that up to 1 in 3 patients may not
respond adequately to their antiplatelet medications
due to numerous factors.2 Patients who do not respond
adequately to their antiplatelet therapies may be at
significantly greater risk of ischemic events and death.3-6 Additionally, powerful new therapies such as prasugrel (Effient) may be used to combat ischemic events, but may put patients at a greater risk of bleeding.7
VerifyNow System – Easy. Rapid. Proven.
The VerifyNow® System is the first rapid and accurate system 
to help physicians determine patients’ platelet response to multiple antiplatelet agents.
Proven in over 200 peer-reviewed publications,8 the VerifyNow System addresses all major types of antiplatelet therapies, including aspirin, P2Y12 inhibitors (e.g. Plavix, Effient, Ticlid®) and IIb/IIIa inhibitors (e.g. ReoPro®, Integrilin®).